NCT02902458

Brief Summary

This study aims to investigate whether follow-up with a psychologist has an impact on the outcome of patients with an implantable automated defibrillator.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
18

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2014

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2014

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2016

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

September 1, 2016

Completed
14 days until next milestone

First Posted

Study publicly available on registry

September 15, 2016

Completed
Last Updated

September 15, 2016

Status Verified

September 1, 2016

Enrollment Period

1.9 years

First QC Date

September 1, 2016

Last Update Submit

September 12, 2016

Conditions

Keywords

implantable cardioverter defibrillatorprimary preventionpsychological follow-upanxietydepressionquality of life

Outcome Measures

Primary Outcomes (6)

  • Mini International Neuropsychiatric Interview score

    48 hours after implantation

  • Mini International Neuropsychiatric Interview score

    2 weeks after implantation

  • Mini International Neuropsychiatric Interview score

    2 months after implantation

  • Mini International Neuropsychiatric Interview score

    4 months after implantation

  • Mini International Neuropsychiatric Interview score

    6 months after implantation

  • Mini International Neuropsychiatric Interview score

    12 months after implantation

Secondary Outcomes (18)

  • Quality of life

    48 hours after implantation

  • Quality of life

    2 weeks after implantation

  • Quality of life

    2 months after implantation

  • Quality of life

    4 months after implantation

  • Quality of life

    6 months after implantation

  • +13 more secondary outcomes

Study Arms (2)

Psychological follow-up

EXPERIMENTAL

Patients undergoing implantation of an ICD for primary prevention will have an individual interview with a qualified psychologist in addition to standard medical follow-up.

Other: Individual interview with a qualified psychologist

Control

NO INTERVENTION

Patients undergoing implantation of an ICD for primary prevention will have standard medical follow-up.

Interventions

Individual, recorded interview with a qualified psychologist to discuss any and all subjects related to the ICD implantation, or any other topics deemed relevant by the patient.

Psychological follow-up

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • adult patients (aged 18 years or over)
  • indication for implantation of an ICD for primary prophylaxis
  • written informed consent provided
  • patients with social security coverage

You may not qualify if:

  • patients under legal tutorship or guardianship
  • patients with no social security coverage
  • patients unable to complete the questionnaires (language barriers, mentally deficient, illiteracy or dementia)
  • patients awaiting heart transplant
  • patients who refuse to provide written informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Besancon

Besançon, Besancon, 25000, France

Location

MeSH Terms

Conditions

Anxiety DisordersDepression

Condition Hierarchy (Ancestors)

Mental DisordersBehavioral SymptomsBehavior

Study Officials

  • Alexandre Guignier, MD

    Centre Hospitalier Universitaire de Besancon

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 1, 2016

First Posted

September 15, 2016

Study Start

September 1, 2014

Primary Completion

August 1, 2016

Study Completion

August 1, 2016

Last Updated

September 15, 2016

Record last verified: 2016-09

Data Sharing

IPD Sharing
Will not share

Locations